BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 31130302)

  • 1. Regulatory dendritic cells for human organ transplantation.
    Thomson AW; Metes DM; Ezzelarab MB; Raïch-Regué D
    Transplant Rev (Orlando); 2019 Jul; 33(3):130-136. PubMed ID: 31130302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies.
    Thomson AW; Humar A; Lakkis FG; Metes DM
    Hum Immunol; 2018 May; 79(5):314-321. PubMed ID: 29100944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory dendritic cell therapy in organ transplantation.
    Hadjiyannis Y; Thomson AW
    Curr Opin Organ Transplant; 2024 Apr; 29(2):121-130. PubMed ID: 37991065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective Clinical Testing of Regulatory Dendritic Cells in Organ Transplantation.
    Thomson AW; Zahorchak AF; Ezzelarab MB; Butterfield LH; Lakkis FG; Metes DM
    Front Immunol; 2016; 7():15. PubMed ID: 26858719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation and functional assessment of nonhuman primate regulatory dendritic cells and their therapeutic efficacy in renal transplantation.
    Thomson AW; Ezzelarab MB
    Cell Immunol; 2020 May; 351():104087. PubMed ID: 32197811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerogenic dendritic cell therapy in organ transplantation.
    Moreau A; Alliot-Licht B; Cuturi MC; Blancho G
    Transpl Int; 2017 Aug; 30(8):754-764. PubMed ID: 27864897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory T cells: first steps of clinical application in solid organ transplantation.
    van der Net JB; Bushell A; Wood KJ; Harden PN
    Transpl Int; 2016 Jan; 29(1):3-11. PubMed ID: 25981203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory dendritic cells: profiling, targeting, and therapeutic application.
    Thomson AW; Ezzelarab MB
    Curr Opin Organ Transplant; 2018 Oct; 23(5):538-545. PubMed ID: 30036199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-Derived Suppressor Cells as a Regulator of Immunity in Organ Transplantation.
    Nakamura T; Ushigome H
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manufacturing and validation of Good Manufacturing Practice-compliant regulatory dendritic cells for infusion into organ transplant recipients.
    Zahorchak AF; DeRiggi ML; Muzzio JL; Sutherland V; Humar A; Lakkis FG; Hsu YS; Thomson AW
    Cytotherapy; 2023 Apr; 25(4):432-441. PubMed ID: 36639251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orchestration of transplantation tolerance by regulatory dendritic cell therapy or in-situ targeting of dendritic cells.
    Morelli AE; Thomson AW
    Curr Opin Organ Transplant; 2014 Aug; 19(4):348-56. PubMed ID: 24926700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell therapy approaches aiming at minimization of immunosuppression in solid organ transplantation.
    Fändrich F
    Curr Opin Organ Transplant; 2010 Dec; 15(6):703-8. PubMed ID: 20930635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells,tolerance and therapy of organ allograft rejection.
    Raimondi G; Thomson AW
    Contrib Nephrol; 2005; 146():105-120. PubMed ID: 15567925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulatory Cell Therapy in Organ Transplantation: Achievements and Open Questions.
    Fortunato M; Morali K; Passeri L; Gregori S
    Front Immunol; 2021; 12():641596. PubMed ID: 33708227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell Therapy in Solid Organ Transplantation.
    Cai S; Chandraker A
    Curr Gene Ther; 2019; 19(2):71-80. PubMed ID: 31161989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerogenic Dendritic Cells in Solid Organ Transplantation: Where Do We Stand?
    Marín E; Cuturi MC; Moreau A
    Front Immunol; 2018; 9():274. PubMed ID: 29520275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High PD-L1/CD86 MFI ratio and IL-10 secretion characterize human regulatory dendritic cells generated for clinical testing in organ transplantation.
    Zahorchak AF; Macedo C; Hamm DE; Butterfield LH; Metes DM; Thomson AW
    Cell Immunol; 2018 Jan; 323():9-18. PubMed ID: 29217299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Future immunosuppression in organ transplantation: treating the innate immune system of the deceased donor--start tomorrow.
    Land WG
    Exp Clin Transplant; 2012 Jun; 10(3):195-208. PubMed ID: 22631054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulatory dendritic cell therapy: from rodents to clinical application.
    Raïch-Regué D; Glancy M; Thomson AW
    Immunol Lett; 2014 Oct; 161(2):216-21. PubMed ID: 24316407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific alloantigen self-control by regulatory T cells in organ transplantation: a review.
    Boschiero L; Nacchia F; Fior F; Cordiano C; Tridente G; Bellisola G
    Transplant Proc; 2007; 39(6):2013-7. PubMed ID: 17692679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.